
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Centrient Pharmaceuticals (until December 2018 known as DSM Sinochem Pharmaceuticals) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition. Headquartered in Rotterdam, Netherlands, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital, a leading global investment firm
Sustainable antibiotics,enzymatically produced beta-lactam antibiotics,enzymatically produced statins,enzymatically produced generic apis,and drug products with pureactives api
Dsm sinochem pharmaceuticals operates in the Pharmaceutical manufacturing industry.
Dsm sinochem pharmaceuticals's revenue is 11m - 100m
Dsm sinochem pharmaceuticals has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.